|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.89 USD | -0.10% |
|
+5.84% | -28.11% |
| Dec. 12 | Morgan Stanley Adjusts Moderna Price Target to $28 From $30, Maintains Equalweight Rating | MT |
| Dec. 12 | Rate Cuts Can't Buy Confidence |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| $35.37 | +18.33% | 19 | |||||||
| $789.17 | +5.74% | 26 | |||||||
| A$156.99 | +33.5% | 16 | |||||||
| ₩2,203,354.67 | +23.09% | 25 | |||||||
| €264.67 | +11.44% | 18 | |||||||
| $180.17 | +5.06% | 29 | |||||||
| $99.62 | +2.67% | 21 | |||||||
| HK$99.89 | +36.01% | 25 | |||||||
| ₩522,000 | +23.26% | 5 | |||||||
| $85.78 | +13.33% | 18 | |||||||
| - | - | - | - | - | |||||
| SEK 367.09 | +15.8% | 11 | |||||||
| $74 | +2.82% | 11 | |||||||
| $88.48 | +70.91% | 25 | |||||||
| HK$34.74 | +49.56% | 11 | |||||||
| - | - | CN¥50 | +8.62% | 1 | |||||
| €15.2 | +40.68% | 12 | |||||||
| $179.74 | +22.38% | 20 | |||||||
| $223 | -6.52% | 10 | |||||||
| Average | 151,561.03 | +20.93% | 17 | ||||||
| Weighted average by Cap. | 316,468.16 | +18.37% | 20 |
- Stock Market
- Equities
- MRNA Stock
- Sector Moderna, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
















